Yuka Sugiura

Title: Yuka Sugiura: Innovator in Tear Fluid Evaluation and Biologically Active Substances

Introduction

Yuka Sugiura, hailing from Higashimurayama, Japan, is a remarkable inventor recognized for her contributions to the field of biomedical applications. With two patents to her name, Sugiura has demonstrated a commitment to innovation that addresses critical healthcare needs.

Latest Patents

Sugiura's most recent patents include:

1. **Method for Dynamic Evaluation of Tear Fluid Layer**: This invention outlines a comprehensive method for dynamically assessing a tear fluid layer through the use of interference fringe images, composed of multiple consecutive frames. The process involves several steps, including image creation to detect breaking sites, determining whether the created images correlate with a predetermined breakup pattern, tallying results from the determination phase, and finally evaluating the breakup pattern based on these tallied results.

2. **Method for Measuring Physiologically Active Substances of Biological Origin**: This patent focuses on assessing the start time of the limulus reaction between biogenous biologically active substances and LAL (Limulus Amebocyte Lysate). Sugiura's method effectively detects variations in transmitted or scattered light in the liquid mixture during measurement, disregarding the influence of progressive changes unrelated to the limulus reaction. The time when these variations cross a threshold is marked as the reaction start time, allowing for accurate concentration determination of the biogenous substances.

Career Highlights

Throughout her career, Sugiura has contributed her expertise to notable organizations including Kowa Company Limited and Kyoto Prefectural Public University Corporation. These roles have significantly influenced her development and implementation of groundbreaking inventions.

Collaborations

In her journey of innovation, Sugiura has collaborated with esteemed colleagues such as Katsumi Yabusaki and Norihiko Yokoi. Their partnerships have undoubtedly enriched her research endeavors and contributed to the success of her patents.

Conclusion

Yuka Sugiura exemplifies the spirit of innovation through her groundbreaking patents relating to tear fluid evaluation and biologically active substances. Her career reflects a dedication to improving healthcare technologies, with collaborations that bolster her contributions. As she continues to innovate, her work remains a valuable asset in the biomedical field.